Legal & General Group’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Legal & General Group’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-5,443	Closed	-$223K	–	2817
2015 Q2	$223K	Buy	5,443 +760	+16%	+$27.2K	﹤0.01%	1699
2015 Q1	$165K	Buy	4,683 +1,148	+32%	+$38.8K	﹤0.01%	1770
2014 Q4	$116K	Hold	3,535	–	–	﹤0.01%	1867
2014 Q3	$100K	Buy	+3,535	New	+$108K	﹤0.01%	1890

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Legal & General Group's BRLI Position: Q3 2015 in Review

Legal & General Group sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 5,443 shares — an estimated $223K sold.

Legal & General Group first reported a position in BRLI in Q3 2014 and held it in 4 quarters. The position peaked at $223K in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

Legal & General Group reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
Legal & General Group sold 5,443 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $223K.
Legal & General Group first reported a position in BIO-REFERENCE LABS INC-NEW- in Q3 2014 and held it in 4 quarters.
Legal & General Group's BIO-REFERENCE LABS INC-NEW- position peaked at $223K in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Legal & General Group's 13F filing for Q3 2015, filed 13 Nov 2015.